✦ LIBER ✦

A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancer

✍ Scribed by Kawahara, Akihiko; Taira, Tomoki; Azuma, Koichi; Tominaga, Masaki; Hattori, Satoshi; Kawahara, Mayuko; Abe, Hideyuki; Yamaguchi, Tomohiko; Akiba, Jun; Takamori, Shinzo; Hayashi, Akihiro; Kage, Masayoshi

Book ID: 119320937
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 641 KB
Volume: 78
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2012.07.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)

✍ Elena María Martínez-Navarro; Joseba Rebollo; Ramón González-Manzano; Manuel Sur 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 230 KB

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI

✍ Yi, Hyeon Gyu; Kim, Hye Jin; Kim, Yu Jung; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Ho 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 130 KB

KRAS mutations and resistance to EGFR-TK

KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies

✍ Mao, Chen; Qiu, Li-Xin; Liao, Ru-Yan; Du, Fang-Bing; Ding, Hong; Yang, Wan-Chun; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Response to Treatment and Survival of Pa

Response to Treatment and Survival of Patients with Non-Small Cell Lung Cancer Undergoing Somatic EGFR Mutation Testing

✍ Sequist, L. V.; Joshi, V. A.; Janne, P. A.; Muzikansky, A.; Fidias, P.; Meyerson 📂 Article 📅 2007 🏛 Alphamed Press 🌐 English ⚖ 105 KB

Usefulness of cumulative smoking dose fo

Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment

✍ Masaru Jida; Shinichi Toyooka; Tetsuya Mitsudomi; Toshimi Takano; Keitaro Matsuo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB

Monitoring reversible and irreversible E

Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PET

✍ Scheffler, Matthias; Kobe, Carsten; Zander, Thomas; Nogova, Lucia; Kahraman, Den 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 510 KB